Atlas Trials

The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary Hyperparathyroidism

Clinical trial NCT03831620 · COMPLETED

Trial details

NCT number
NCT03831620
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
COMPLETED
Study type
OBSERVATIONAL
Primary Hyperparathyroidism
Start date
2019-02-01
Primary completion
2022-07-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.